173 related articles for article (PubMed ID: 26984141)
1. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.
Bellanger AP; Tatara AM; Shirazi F; Gebremariam T; Albert ND; Lewis RE; Ibrahim AS; Kontoyiannis DP
J Infect Dis; 2016 Jul; 214(1):114-21. PubMed ID: 26984141
[TBL] [Abstract][Full Text] [Related]
2. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Bellanger AP; Albert ND; Lewis RE; Walsh TJ; Kontoyiannis DP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7830-2. PubMed ID: 26392499
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
Lewis RE; Ben-Ami R; Best L; Albert N; Walsh TJ; Kontoyiannis DP
J Infect Dis; 2013 Mar; 207(5):834-41. PubMed ID: 23242544
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection.
Ben-Ami R; Lewis RE; Tarrand J; Leventakos K; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Jan; 54(1):484-90. PubMed ID: 19858263
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Posaconazole against Rhizopus oryzae Infection in Silkworm.
Kurakado S; Matsumoto Y; Sugita T
Med Mycol J; 2021; 62(3):53-57. PubMed ID: 34471035
[TBL] [Abstract][Full Text] [Related]
7. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.
Gebremariam T; Lin L; Liu M; Kontoyiannis DP; French S; Edwards JE; Filler SG; Ibrahim AS
J Clin Invest; 2016 Jun; 126(6):2280-94. PubMed ID: 27159390
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
9. Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes.
Galgóczy L; Papp T; Lukács G; Leiter E; Pócsi I; Vágvölgyi C
FEMS Microbiol Lett; 2007 May; 270(1):109-15. PubMed ID: 17302920
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.
Ibrahim AS; Bowman JC; Avanessian V; Brown K; Spellberg B; Edwards JE; Douglas CM
Antimicrob Agents Chemother; 2005 Feb; 49(2):721-7. PubMed ID: 15673756
[TBL] [Abstract][Full Text] [Related]
11. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus.
Gebremariam T; Alkhazraji S; Alqarihi A; Wiederhold NP; Shaw KJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205345
[TBL] [Abstract][Full Text] [Related]
12. Deferiprone iron chelation as a novel therapy for experimental mucormycosis.
Ibrahim AS; Edwards JE; Fu Y; Spellberg B
J Antimicrob Chemother; 2006 Nov; 58(5):1070-3. PubMed ID: 16928702
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of statins against Aspergillus species.
Qiao J; Kontoyiannis DP; Wan Z; Li R; Liu W
Med Mycol; 2007 Nov; 45(7):589-93. PubMed ID: 18033614
[TBL] [Abstract][Full Text] [Related]
14. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.
Rodríguez MM; Pastor FJ; Sutton DA; Calvo E; Fothergill AW; Salas V; Rinaldi MG; Guarro J
Antimicrob Agents Chemother; 2010 May; 54(5):1665-9. PubMed ID: 20145077
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Activity of Amphotericin B in Combination with Statins against Clinical and Environmental
Naeimi Eshkaleti M; Kordbacheh P; Hashemi SJ; Falahati M; Zaini F; Mirhendi H; Safara M; Hosseinpoor L
Iran J Public Health; 2019 May; 48(5):943-948. PubMed ID: 31523652
[TBL] [Abstract][Full Text] [Related]
16. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.
Waldorf AR; Ruderman N; Diamond RD
J Clin Invest; 1984 Jul; 74(1):150-60. PubMed ID: 6736246
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.
Shirazi F; Kontoyiannis DP
PLoS One; 2013; 8(5):e63393. PubMed ID: 23696824
[TBL] [Abstract][Full Text] [Related]
19. In vitro interactions between primycin and different statins in their effects against some clinically important fungi.
Nyilasi I; Kocsubé S; Pesti M; Lukács G; Papp T; Vágvölgyi C
J Med Microbiol; 2010 Feb; 59(Pt 2):200-205. PubMed ID: 19875509
[TBL] [Abstract][Full Text] [Related]
20. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.
Gebremariam T; Alkhazraji S; Soliman SSM; Gu Y; Jeon HH; Zhang L; French SW; Stevens DA; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
Sci Adv; 2019 Jun; 5(6):eaaw1327. PubMed ID: 31206021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
